Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73256263)
Watch
English
Treatment of ocular inflammatory disorders with daclizumab
scientific article published on 01 April 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
title
Treatment of ocular inflammatory disorders with daclizumab
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
main subject
ophthalmology
1 reference
stated in
Crossref
DOI
10.1016/S0161-6420(02)01932-2
reference URL
https://api.crossref.org/works/10.1016/S0161-6420(02)01932-2
retrieved
23 December 2023
author name string
David Chu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
George N. Papaliodis
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689903
retrieved
23 December 2023
C. Stephen Foster
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689903
retrieved
23 December 2023
language of work or name
English
1 reference
stated in
National Center for Biotechnology Information
PubMed publication ID
12689903
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12689903
retrieved
23 December 2023
publication date
1 April 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
full work available at URL
https://api.elsevier.com/content/article/PII:S0161642002019322?httpAccept=text/xml
1 reference
stated in
Crossref
DOI
10.1016/S0161-6420(02)01932-2
reference URL
https://api.crossref.org/works/10.1016/S0161-6420(02)01932-2
retrieved
23 December 2023
https://api.elsevier.com/content/article/PII:S0161642002019322?httpAccept=text/plain
1 reference
stated in
Crossref
DOI
10.1016/S0161-6420(02)01932-2
reference URL
https://api.crossref.org/works/10.1016/S0161-6420(02)01932-2
retrieved
23 December 2023
published in
Ophthalmology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
volume
110
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
issue
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
page(s)
786-789
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
cites work
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of recalcitrant psoriasis with daclizumab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901932-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0161-6420(02)01932-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
PubMed publication ID
12689903
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12689903
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12689903%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
